Bluebird Bio Inc (BLUE)

[MiamiGent]

BLUE Listened to the CC as well as possible. CEO was a poor speaker, ate his words, did not project.
It was a review of where things stand. No startling good news like a buyout.
But some solid good info: cash flow will be sufficient to take them into 2024. So that means NO near term offering. That's great because it was a concern.
There is a SSR on today because the SP fell 10% on Friday. So shorters will be handicapped.
It's a good story and could move up today. Right now it is only up 4.5% which does afford a buy-in. It's either a scalp or a good hold.
Other than the red market (which could change) there is no reason this can't move today. This second approval in a month validates BLUE's platform and their next candidate addresses a big market.
I've seen much lessor bios zoom.
MG

https://stockcharts.com/h-sc/ui?s=BLUE